Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Differential effect of Carbamazepine on cortical excitability by SCN1A genotype
DRKS00000788Phase 2Completed
- Sponsor
- Philipps-Universität Marburg
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of carbamazepine in epilepsy (2 arms), sponsored by Philipps-Universität Marburg. Primary endpoint: Change in cortical excitability after carbamazepine vs placebo. Started Apr 2011; status: completed.
02
Drugs
carbamazepine
03
Conditions
epilepsy
Beyond the preview
Go deeper on DRKS00000788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000788.